Yesterday, Crystal Research CEO Jeffrey Kraws and NPR's correspondent Yuki Noguchi discussed the impact of a U.S. Supreme Court decision that allows generic drug makers to challenge brand-name rivals suspected of overstating the reach of their patents in regulatory filings. The full audio clip and transcript are available here.